These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Do- do not: in case of menometrorrhagia in IUD users]. Guery MF Contracept Fertil Sex (Paris); 1979 Dec; 7(12):928-9. PubMed ID: 12261435 [TBL] [Abstract][Full Text] [Related]
24. Effective, despite misconceptions. The IUD with progesterone must be replaced once a year, while the IUD with copper may be left in for up to 10 years. Indian Med Trib; 1996 Mar; 4(5):9. PubMed ID: 12179197 [TBL] [Abstract][Full Text] [Related]
26. [Intrauterine contraception from the viewpoint of an ambulatory gynecologic department]. Hagen P Z Arztl Fortbild (Jena); 1981 Sep; 75(17):800-4. PubMed ID: 7345787 [TBL] [Abstract][Full Text] [Related]
27. Hysteroscopic assessment of abnormal uterine bleeding in users of the intrauterine contraceptive device. Kulkarni S; Wynter HH; Desai P West Indian Med J; 1993 Sep; 42(3):124-5. PubMed ID: 8273322 [TBL] [Abstract][Full Text] [Related]
28. [Contraindications for the use of copper T intrauterine pessaries]. Wagner H; Schmidt EH Med Welt; 1976 Aug; 27(35):1631-4. PubMed ID: 957993 [TBL] [Abstract][Full Text] [Related]
29. Use of a levonorgestrel-releasing intrauterine device for the symptomatic treatment of uterine myomas. Rosa e Silva JC; de Sá Rosa e Silva AC; Cândido dos Reis FJ; Manetta LA; Ferriani RA; Nogueira AA J Reprod Med; 2005 Aug; 50(8):613-7. PubMed ID: 16220768 [TBL] [Abstract][Full Text] [Related]
30. [Intrauterine contraceptive devices. Mode of action, experiences, complications (author's transl)]. Ludwig H Geburtshilfe Frauenheilkd; 1976 Feb; 36(2):97-108. PubMed ID: 943359 [TBL] [Abstract][Full Text] [Related]
31. [Value of intrauterine contraception]. Neumann HG Z Arztl Fortbild (Jena); 1985; 79(10):449-51. PubMed ID: 4049935 [TBL] [Abstract][Full Text] [Related]
32. [Non-hormonal methods of female contraception]. Audebert AJ Rev Prat; 1987 Sep; 37(38):2255-65. PubMed ID: 3659792 [TBL] [Abstract][Full Text] [Related]
33. The risk of pelvic inflammatory disease in women using intra-uterine device--a prospective study at the Kenyatta National Hospital. Abdulla SH J Obstet Gynaecol East Cent Africa; 1982 Dec; 1(4):156-8. PubMed ID: 12313676 [TBL] [Abstract][Full Text] [Related]
34. IUD use and unexplained vaginal bleeding. Huggins GR Obstet Gynecol; 1981 Oct; 58(4):409-16. PubMed ID: 7279336 [TBL] [Abstract][Full Text] [Related]
35. [Dependence of deposits-composition present on the surface IUD "dana super" upon the duration of insertion (author's transl)]. Nesit V; Pĕtros J; Garcic A Cesk Gynekol; 1978 Nov; 43(9):692-6. PubMed ID: 709634 [TBL] [Abstract][Full Text] [Related]
36. [A comparative study of the Copper T 200 IUD with or without string]. Cohen J Contracept Fertil Sex (Paris); 1987 Dec; 15(12):1157-60. PubMed ID: 12341738 [TBL] [Abstract][Full Text] [Related]
37. [A case report of uterine hemorrhage following the insertion of the Medusa intrauterine contraceptive device in the presence of uterine adenomyosis]. Cherveniashki S; Vasilev D Akush Ginekol (Sofiia); 1990; 29(4):81-2. PubMed ID: 2267989 [No Abstract] [Full Text] [Related]
38. Statement on intrauterine devices (IUDs). International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP IPPF Med Bull; 1987 Dec; 21(6):3-5. PubMed ID: 12268853 [TBL] [Abstract][Full Text] [Related]